City

Austin (1)

Beijing (1)

Hershey (1)

Condition

Malignancies Multiple (3)

Overall Status

Completed (1)

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Bristol-Myers Squibb (1)

Han weidong (1)

Monika Joshi (1)

Collaborator

Intervention

anti-pd-1 antibody (1)

bms-986205 (1)

chemotherapy (1)

covid-19 vaccine hesitancy and acceptance survey (1)

decitabine (1)

itraconazole (1)

rifampin (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Observational (1)

malignancies multiple

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Coronavirus Disease 2019 Vaccination in Cancer Patients

Recruiting

Malignancies Multiple

COVID-19 vaccine hesitancy and acceptance survey

Hershey, Pennsylvania

Penn State Cancer Institute

Feb 28, 2022

Malignancies Multiple Trial in Beijing (Anti-PD-1 antibody, Decitabine, Chemotherapy)

Unknown status

Malignancies Multiple

Anti-PD-1 antibody
+2 more

Beijing, Beijing, China

Biotherapeutic Department of Chinese PLA General Hospital

Jul 5, 2019

Malignancies Multiple Trial in Austin (BMS-986205, Itraconazole, Rifampin)

Completed

Malignancies Multiple

BMS-986205
+2 more

Austin, Texas

PPD

Feb 26, 2018